Centers | ||
|
|
|
Institut de Pharmacologie de Sherbrooke (IPS) | Therapeutic Accelerator Program (TAP) | UCL TRO Drug Discovery Group |
Institut de Pharmacologie de Sherbrooke focuses on the discovery of new drugs and new diagnostic agents , as well as the validation of emerging drug targets and new technologies to support drug discovery. Major areas of focus include cardiovascular... Read more |
Test |
UCL Translational Research Office(TRO) builds on an increasingly vibrant translational culture across the School of Life and Medical Sciences (SLMS) and the wider university community by providing integrated support for translational research,... |
Partnerships |
Events |
Jobs |
Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial DrugsBroad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at Broad while Astra Zeneca will be responsible for... View all Takeda Partners with Florida Hospital & Sanford-Burnham in Obesity AreaTakeda Pharmaceuticals has entered into a collaboration with Florida Hospital and Sanford-Burnham Medical Institute to discover and develop new therapeutic approaches to treat obesity. The two collaboration agreement will involve Takeda providing... View all Johns Hopkins BSi Licenses GCPII Assets from EisaiJohns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted... View all |
   Join us for breakfast, lunch, or cocktails in your local time zone for our monthly webinar series on... 06 May, 2021 |
Postdoctoral Associate
... 15 February, 2021 Learn More Postdoctoral Associate ... 03 March, 2021 Learn More POSTDOCTORAL RESEARCH ASSOCIATE (Neuroscience)
id: 21775 Postdoctoral Fellow (T Cell Immunology)
id: 21776 |
